Engineers Gate Manager’s Teva Pharmaceuticals TEVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $592K | Sell |
35,340
-70,355
| -67% | -$1.18M | 0.01% | 1404 |
|
2025
Q1 | $1.62M | Buy |
+105,695
| New | +$1.62M | 0.03% | 795 |
|
2024
Q4 | – | Sell |
-50,157
| Closed | -$904K | – | 2569 |
|
2024
Q3 | $904K | Buy |
50,157
+26,015
| +108% | +$469K | 0.02% | 1058 |
|
2024
Q2 | $392K | Sell |
24,142
-35,627
| -60% | -$579K | 0.01% | 1330 |
|
2024
Q1 | $843K | Sell |
59,769
-29,693
| -33% | -$419K | 0.02% | 925 |
|
2023
Q4 | $934K | Buy |
89,462
+63,140
| +240% | +$659K | 0.03% | 833 |
|
2023
Q3 | $268K | Sell |
26,322
-53,034
| -67% | -$541K | 0.01% | 1369 |
|
2023
Q2 | $598K | Buy |
79,356
+22,457
| +39% | +$169K | 0.02% | 950 |
|
2023
Q1 | $504K | Sell |
56,899
-17,126
| -23% | -$152K | 0.02% | 971 |
|
2022
Q4 | $675K | Buy |
74,025
+59,220
| +400% | +$540K | 0.04% | 723 |
|
2022
Q3 | $119K | Sell |
14,805
-17,295
| -54% | -$139K | 0.01% | 1422 |
|
2022
Q2 | $241K | Buy |
+32,100
| New | +$241K | 0.01% | 1549 |
|
2022
Q1 | – | Sell |
-67,000
| Closed | -$537K | – | 2303 |
|
2021
Q4 | $537K | Buy |
67,000
+56,600
| +544% | +$454K | 0.02% | 1000 |
|
2021
Q3 | $101K | Buy |
+10,400
| New | +$101K | 0.01% | 1531 |
|
2021
Q2 | – | Sell |
-27,960
| Closed | -$323K | – | 2009 |
|
2021
Q1 | $323K | Buy |
27,960
+10,960
| +64% | +$127K | 0.02% | 1275 |
|
2020
Q4 | $164K | Sell |
17,000
-17,900
| -51% | -$173K | 0.01% | 1521 |
|
2020
Q3 | $314K | Sell |
34,900
-39,073
| -53% | -$352K | 0.01% | 1223 |
|
2020
Q2 | $912K | Buy |
73,973
+30,236
| +69% | +$373K | 0.05% | 641 |
|
2020
Q1 | $393K | Sell |
43,737
-14,263
| -25% | -$128K | 0.03% | 908 |
|
2019
Q4 | $568K | Buy |
58,000
+42,900
| +284% | +$420K | 0.03% | 930 |
|
2019
Q3 | $104K | Buy |
15,100
+3,500
| +30% | +$24.1K | 0.01% | 1306 |
|
2019
Q2 | $107K | Buy |
+11,600
| New | +$107K | 0.01% | 1054 |
|